Allspring Global Investments Holdings LLC Purchases 507,674 Shares of Revvity Inc. $RVTY

Allspring Global Investments Holdings LLC increased its position in shares of Revvity Inc. (NYSE:RVTY) by 29.0% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,259,286 shares of the company’s stock after buying an additional 507,674 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Revvity were worth $198,636,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD lifted its stake in Revvity by 5.3% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,606,637 shares of the company’s stock valued at $832,693,000 after acquiring an additional 434,570 shares during the last quarter. Janus Henderson Group PLC grew its position in shares of Revvity by 7.0% in the 4th quarter. Janus Henderson Group PLC now owns 8,161,171 shares of the company’s stock valued at $789,595,000 after acquiring an additional 533,912 shares during the period. Morgan Stanley increased its stake in shares of Revvity by 29.6% during the 4th quarter. Morgan Stanley now owns 2,844,464 shares of the company’s stock worth $275,202,000 after purchasing an additional 650,083 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Revvity by 22.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,612,116 shares of the company’s stock worth $252,727,000 after purchasing an additional 486,159 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in shares of Revvity by 15.7% in the 3rd quarter. Invesco Ltd. now owns 2,553,515 shares of the company’s stock valued at $223,816,000 after purchasing an additional 346,313 shares during the period. 86.65% of the stock is owned by institutional investors.

Revvity Stock Performance

RVTY opened at $111.65 on Friday. The business has a fifty day simple moving average of $103.38 and a 200 day simple moving average of $99.08. The company has a market capitalization of $12.46 billion, a PE ratio of 53.42, a price-to-earnings-growth ratio of 2.19 and a beta of 1.09. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $118.30. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.04. The firm had revenue of $711.12 million for the quarter, compared to analysts’ expectations of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The company’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Research analysts expect that Revvity Inc. will post 5.25 EPS for the current year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th. Revvity’s dividend payout ratio (DPR) is currently 13.40%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on RVTY. Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. The Goldman Sachs Group lowered their price target on Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 14th. Evercore restated an “outperform” rating and issued a $125.00 price objective on shares of Revvity in a research note on Monday, July 6th. Barclays raised their price objective on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Finally, Wolfe Research assumed coverage on Revvity in a report on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Four equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Revvity currently has an average rating of “Hold” and an average target price of $108.92.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.